Keep clinical AI inside approved care pathways
Healthcare teams do not need more generic AI governance prose. They need runtime controls that stop unapproved clinical actions, preserve patient-safe context, and produce evidence quality teams can actually review.
The workflow pain
The bottleneck is not whether the model can answer. It is whether the organisation can trust the answer to change patient care, expose PHI, or trigger a regulated workflow.
What breaks
Clinical copilots drift from summarisation into recommendation, internal assistants access the wrong context, or outbound messages carry language that should have been reviewed by a human.
Why rollout stalls
Quality, clinical safety, privacy, and security teams need a way to intercept the action before it lands in a patient-facing or clinician-facing system.
What wins approval
A governed execution path that proves when the AI was blocked, when it was reviewed, and exactly what context informed the final approved action.
Runtime control loop
Healthcare AI needs the ability to block, review, and allow actions at the moment of execution.
Block
Prevent copilots from sending unapproved clinical recommendations, unsafe instructions, or unauthorised PHI disclosures.
Review
Route high-stakes decisions to clinicians or quality reviewers with the exact patient-safe context they need.
Allow
Release only the approved action and record the reviewer identity, policy result, and downstream effect.
Governed examples
- Escalate discharge-plan recommendations before they reach the patient-facing channel
- Require review when care-navigation assistants cross from summarisation into recommendation
- Block outbound messages containing PHI or unapproved treatment language
What reviewers ask for
- Prompt, model, and workflow version used in the governed decision path
- Reviewer assignment, approval or rejection outcome, and timestamp
- Execution lineage proving no unauthorised action reached a patient or downstream system
Clinical AI sits inside professional and safety accountability, not just IT risk
A care assistant that drifts from drafting into directing care is not a model-quality issue — it is a clinician-accountability and patient-safety issue. The binding pressure comes from clinical governance, professional duty of care, and data-protection obligations over patient data, with the EU AI Act adding human-oversight and record-keeping discipline on top.
The failure mode in the wild
A care-navigation or discharge assistant summarises a chart, then quietly crosses into recommending a treatment change or messaging a patient — without a clinician ever confirming it. The organisation cannot show who was accountable for that action or what patient context produced it. That gap is what stalls clinical rollout, not the model's accuracy on a benchmark.
How KLA maps controls to the obligation
- A runtime gate intercepts the action — send, recommend, disclose — before it commits, returning allow, warn, require approval, or block.
- Care-affecting and PHI-disclosing steps route to a named clinician or reviewer in a maker-checker gate, satisfying the human-oversight expectation.
- Each governed decision is sealed into lineage that doubles as the record-keeping evidence quality and safety teams replay during review.
Related workflow blueprint
When a clinical assistant touches adverse-event detection or reporting, the same intake-and-case-processing discipline applies. The pharmacovigilance blueprint shows the runtime checkpoints — case validity, seriousness, coding, and reporting deadlines — that KLA enforces on an agent you already built, with a lineage record that doubles as a Part 11 audit trail.